Oral Anticoagulation
Effect of a combined education and eHealth programme on the control of oral anticoagulation patients (PORTALS study): a parallel cohort design in Dutch primary care
... between anticoagulation self-management patients trained by e-learning and by group ...receiving oral anticoagulation ...of oral anticoagula- tion self-management, including ...
12
Oral anticoagulation therapy: current challenges in Indian scenario
... on oral anticoagulation ...areas. Anticoagulation therapy reduces the incidence of stroke and systemic embolism in patients with AF and mechanical heart ...for anticoagulation therapy in the ...
9
Assessment of psychometric properties of the Brazilian version of the oral anticoagulation knowledge test
... Methods: This study, conducted in an anticoagulation clinic, included 201 Brazilian participants aged over 18 years, who had been using warfarin for more than two months. The reliability of the instrument was ...
9
ASSESSMENT OF ORAL ANTICOAGULATION KNOWLEDGE AMONG RURAL INDIAN POPULATION
... measure anticoagulation knowledge among Malaysian community: A translation and validation study of the Oral Anticoagulation Knowledge (OAK) ...
7
Assessing differential attrition in clinical trials: self-monitoring of oral anticoagulation and type II diabetes
... We searched Medline and the Cochrane library from the beginning of the databases to May 2006 for published sys- tematic reviews that compared the effects of self-monitor- ing (self-testing) or self-management ...
12
Oral anticoagulation to reduce risk of stroke in patients with atrial fibrillation: current and future therapies
... population. Oral anticoagulation with warfarin has been the pharmacologic standard for stroke risk reduction in patients with ...ie, oral anticoagulants with novel mechanisms of action, have recently ...
10
Risk of major bleeding during extended oral anticoagulation in patients with first unprovoked venous thromboembolism: a systematic review and meta-analysis protocol
... III anticoagulation trials ...extending anticoagulation, from the total number of fatal (bleeding and recurrent PE events) divided by the total number of major bleeding and recurrent VTE events, ...
7
Impact of self funding on patient experience of oral anticoagulation self monitoring : a qualitative study
... If oral anticoagulation therapy self-monitoring devices and consumables were provided free of charge in routine care, the training and support available in England may need to be reviewed to prevent ...
8
Global assays and the management of oral anticoagulation
... an oral anticoagulant depends on the principle of the test and the type of oral ...of oral anticoagulation is a prerequisite when studying potential reversal agents or when managing ...
14
Resumption of oral anticoagulation after spontaneous intracerebral hemorrhage
... requiring oral anticoagulation will ...antagonist oral anticoagulants (NOAC) compared to Vitamin-K-antagonist (VKA), NOAC use should also be preferred after ICH, although specific comparative studies ...
10
Acquired deficiencies of protein S Protein S activity during oral anticoagulation, in liver disease, and in disseminated intravascular coagulation
... during oral anticoagulation, we developed a functional assay for protein S that permits evaluation of the distribution of protein S between free and bound forms and permits determination of the specific ...
11
Reversal of oral anticoagulation in patients with acute intracerebral hemorrhage
... In light of an aging population with increased cardiovascular comorbidity, the use of oral anticoagulation (OAC) is steadily expanding. A variety of pharmacological alternatives to vitamin K antagonists ...
9
Quality of oral anticoagulation with phenprocoumon in regular medical care and its potential for improvement in a telemedicine-based coagulation service – results from the prospective, multi-center, observational cohort study thrombEVAL
... Oral anticoagulation (OAC) therapy is the established therapy to reduce the risk of thromboembolic events in patients with atrial fibrillation ...with oral anticoagulants ...effective oral ...
11
Oral anticoagulation in atrial fibrillation
... New oral anticoagulants in atrial fibrillation and acute coronary syn- dromes: ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease position ...
9
Characteristics and quality of oral anticoagulation treatment in pediatric patients in the Netherlands based on the CAPS cohort
... the anticoagulation clinic (between 11 January 2014 and 10 March 2016), when they became 19 years of age, when they stopped VKA therapy or when they were lost to ...the anticoagulation clinic(s) managing ...
9
Oral anticoagulation in surgical procedures: risks and recommendations
... Patients In the penod between 1994 and 1998, we performed a prospective study among 4200 patients of the Leiden Anticoagulation Chnic to determme the optimal level of oral anticoagulatio[r] ...
8
Optimal oral anticoagulation for patients with mechanical heart valves
... The incidence rates of adverse events for specific levels of intensity of anticoagulation were calculated äs the ratio of the number of events that took place when thc prothrombin time w[r] ...
8
A 10 year study of hospitalized atrial fibrillation-related stroke in England and its association with uptake of oral anticoagulation
... To date, time course studies of temporal changes in AF-related stroke have reached differing conclusions. Data from the Framingham population found a decline in risk of stroke occurring following the onset of AF between ...
9
Stopping or maintaining oral anticoagulation in patients undergoing photoselective vaporization of the prostate (SOAP) surgery for benign prostate obstruction: study protocol for a multicentre randomized controlled trial
... an OAC, and 40% of them are 80 years old or older. Among these patients, 15–20% will undergo an inva- sive procedure or surgery that interrupts their chronic OAC treatment, putting them at increased risk for ...
8
Download Download PDF
... known to increase the anticoagulation eff ects. Approxi- mately - of patients who have or polymorph allele for CYPC, can achieve the therapeutic INR value with the dosing of , mg/day (). Th e ...
7